KRX •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 06/19/2026
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeKRX
Market Capitalization200,419 mln
Float2.35 mln
Earnings Date08/12/2025
EPS
9,767
Exceptional
P / E
4.13
Deeply undervalued
Piotroski F-Score
5
/ 9
Neutral
Beneish M-Score
-2.63
Likely reliable
Relative Strength
38
/ 100
Underperforming
Debt / Equity
0.88
Moderate leverage
Business Description
Founded over 80 years ago and headquartered in Seoul, Chong Kun Dang Holdings is a South Korean company that produces and sells medicine both at home and in markets around the world.
